Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
4,912.00    -48.00 (-0.97%)
Bid:
4,920.00
Ask:
4,940.00
Spread: 20.00 (0.407%)
Market Cap: $1.29t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Repurchase

18 Feb 2025 10:21

RNS Number : 5359X
Samsung Electronics Co. Ld
18 February 2025
 

Decision on Share Repurchase

 

 

1. Number of shares to be repurchased

Common

48,149,247

Other

6,636,988

2. Value of shares to be repurchased (Korean won)

Common

2,696,357,832,000

Other

303,642,201,000

3. Expected repurchase period

Start date

February 19, 2025

End date

May 16, 2025

4. Purpose of repurchase

To increase shareholder value and conduct employee stock-based compensation, etc.

5. Method of repurchase

Open market

6. Consignment investment brokers

Samsung Securities Co., Ltd.

Korea Investment & Securities Co, Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

IBK Securities Co.,Ltd

7. Holding status of treasury shares before repurchase

Repurchase within the allowable distribution profit (shares)

Common

50,144,628

Ratio (%)

0.8

Other

6,912,036

Ratio (%)

0.8

Other repurchase (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

8. Date of board resolution (confirmation date)

February 18, 2025

- Attendance of Independent Directors at the Board of Directors meeting

Present

6

Absent

0

- Attendance of auditors who are not

 Independent Directors

0

9. Daily order quantity limit

Common

5,246,563

Other

663,698

 

10. Other Information to Consider:

- Shares denoted as "other" are preferred shares.

- In Item 2 above, the value of shares to be repurchased is based on the closing price on the day before the board resolution (February 17, 2025). The actual amount may change depending on future stock price movements.

 ※ KRW 56,000 per common share and KRW 45,750 per preferred share

-In Item 4, the expected holding period and purpose of repurchase, in accordance with the Board resolution on February 18, 2025, shares worth KRW 500 billion are to be acquired for the purpose of the stock-based compensation including employee incentives, etc. The remaining KRW 2.5 trillion is to be acquired for the purpose of stabilizing the stock price and enhancing shareholder value.

Further details, including timing of cancellation and the actual number of shares to be cancelled, will be disclosed following the resolution of the Board of Directors in the future.

* To enhance motivation for business performance and enhance shareholder value, the Company has decided to implement a stock-based compensation program (RSA) for executive compensation. Under this program, stock-based compensation will constitute 50% or more of the 2024 Overall Performance Incentive (OPI). The Company plans to allocate a portion of the repurchased shares, amounting to approximately KRW 500 billion, to the RSA program.

* Under the RSA framework, the number of treasury shares for each executive was determined in January 2025 based on individual selections. The final allocation will be confirmed one year later, considering the stock price at that time. Once granted, executives will be restricted from selling the shares for a period of one to two years, in accordance with the program's terms.

- In Item 8 above, all Audit Committee members are Independent Directors.

- The calculation method for Item 9 above is the smaller of: [] and [the larger of and ].

  10% of the number of shares to be repurchased: 4,814,924 common; 663,698 preferred

  25% of average daily transaction volume for one month ending the day before the date of the board resolution: 5,246,563 common; 319,492 preferred

  1% of total number of issued shares: 59,697,825 common; 8,228,867 preferred

 

- No shares were repurchased prior to the decision to repurchase shares.

 

- Limit on the amount of repurchased shares (Korean won)

1. Limits to Dividendable profit under Commercial Act as of end-2024

226,239,016,662,399

2. Amount of repurchased shares since end-2024

1,237,265,394,240

3. Amount of dividends on profits and reserves for related profits decided at a general meeting of shareholders since end-2024

-

4. The interim dividend amount and related profit reserves decided by the board of directors since end-2024

-

Limit on the amount of repurchased shares

(1-2-3-4)

225,001,751,268,159

 

- Holding status of treasury shares before purchase (number of shares)

* on-market direct purchase

Stock type

Initial quantity

Changes

End quantity

purchase

disposal

cancellation

common

-

50,144,628

-

-

50,144,628

other

-

6,912,036

-

-

6,912,036

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGMZGRLGKZM
Date   Source Headline
29th Apr 202012:05 pmRNS2019 Business Report
29th Apr 20207:56 amRNSCharitable Contribution
29th Apr 20207:50 amRNSCharitable Contribution
29th Apr 20207:46 amRNSTransaction with Affiliate Company
29th Apr 20207:43 amRNSTransaction with Affiliate Company
29th Apr 20207:40 amRNSTransaction with Affiliate Company
29th Apr 20207:32 amRNSTransaction with Affiliate Company
29th Apr 20207:28 amRNSQuarterly Dividend for First Quarter 2020
29th Apr 20207:20 amRNS2020 1Q Earnings Release
7th Apr 20207:00 amRNSNotice of 1Q 2020 Earnings Release Schedule
7th Apr 20207:00 amRNS1Q 2020 Pre-Earnings Guidance
18th Mar 20208:35 amRNSTransaction with Affiliate Company
18th Mar 20208:19 amRNSResults of the 51st Annual General Meeting
26th Feb 20208:18 amRNSCharitable Contribution
24th Feb 20208:20 amRNS2019 Consolidated Financial Statements
21st Feb 20209:14 amRNSCharitable Contribution
21st Feb 20208:06 amRNSReference Material for 2020 AGM
30th Jan 20207:00 amRNSYear-End Dividend for FY2019
30th Jan 20207:00 amRNS2019 4Q Earnings Release
30th Jan 20207:00 amRNSElectronic Voting
30th Jan 20207:00 amRNSCharitable Contribution
8th Jan 20207:43 amRNSNotice of 4Q 2019 Earnings Release Schedule
8th Jan 20207:00 amRNS4Q 2019 Pre-Earnings Guidance
29th Nov 20197:49 amRNSTransaction with Affiliate Company
29th Nov 20197:00 amRNS2019 3Q Interim Report
29th Nov 20197:00 amRNSCharitable Contribution
31st Oct 20197:06 amRNSTransaction with Affiliate Company
31st Oct 20197:00 amRNS2019 3Q Earnings Release
31st Oct 20197:00 amRNSQuarterly Dividend for Third Quarter 2019
31st Oct 20197:00 amRNSAnnouncement of Capex Plan for FY 2019
8th Oct 20198:07 amRNSNotice of 3Q 2019 Earnings Release Schedule
8th Oct 20197:00 amRNS3Q 2019 Pre-Earnings Guidance
3rd Sep 201910:12 amRNSCourt Judgment Relating to Embezzlement
30th Aug 20197:24 amRNS2019 Half Year Report
31st Jul 20199:38 amRNSSustainability Report 2019
31st Jul 20198:09 amRNSCharitable Contribution
31st Jul 20198:04 amRNSRenewal of Property & Casualty Insurance Policy
31st Jul 20197:00 amRNS2019 2Q Earnings Release
31st Jul 20197:00 amRNSQuarterly Dividend for Second Quarter 2019
5th Jul 20198:04 amRNSNotice of 2Q 2019 Earnings Release Schedule
5th Jul 20197:00 amRNS2Q 2019 Pre-Earnings Guidance
14th Jun 20197:53 amRNSAnnouncement of Investor Relations Event
7th Jun 20197:00 amRNSRecord Date for Proposed Dividends
3rd Jun 201910:32 amRNSCorporate Governance Report FY2018
3rd Jun 20199:27 amRNSCorporate Governance 2018
31st May 20198:08 amRNS2019 1Q Interim Report
30th Apr 20199:21 amRNS2018 Business Report
30th Apr 20199:14 amRNSCharitable Contribution
30th Apr 20199:11 amRNSCharitable Contribution
30th Apr 20199:06 amRNSTransaction with Affiliate Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.